Laboratory Freezers Market: Market Size and Share estimation with Global Forecast
According to the new market research report " Laboratory Freezers Market by Product (Cryopreservation, Plasma Freezer, Explosion-Proof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator) & by End User - Global Forecast to 2021", published by MarketsandMarkets™, The Global Laboratory Freezers Market is projected to reach USD 3.76 Billion by 2021 at a CAGR of 4.6% from 2016 to 2021
Don’t miss out on business opportunities in "Foot and Ankle Devices Market". Speak to our analyst and gain crucial industry insights that will help your business grow:https://www.marketsandmarkets.com/SpeaktoAnalystNew.asp?id=845
The global foot and ankle devices market is segmented on the basis of products, applications, and regions.
Based on products, the foot and ankle devices market is categorized into orthopedic implants and devices, prostheses, and bracing and support devices. In 2015, the orthopedic implants and devices segment is estimated to account for the major share of the foot and ankle devices market.
Browse and in-depth TOC on "Laboratory Freezers Market"
154 - Tables
33 - Figures
183 - Pages
Visit : https://www.marketsandmarkets.com/Market-Reports/laboratory-freezer-market-196600540.html
The global laboratory freezers market is consolidated in nature, with the top five companies accounting for a major market share in 2015. Some of the key players in this market are Thermo Fisher Scientific Inc. (U.S.), Haier Biomedical (China), Eppendorf AG (Germany), Helmer Scientific (U.S.), VWR Corporation (U.S.), ARCTIKO A/S (Europe), Biomedical Solutions Inc. (U.S.), EVERmed S.R.L. (Italy), Philipp Kirsch GmbH (Germany), and Panasonic Healthcare Co., Ltd. (Japan). The leading players in this market have a major focus on new product launches, agreements, collaborations, partnerships, and expansion of their geographic presence in emerging markets. These are the widely adopted strategies by leading players to enhance their revenue streams and achieve sustainable growth in this competitive market.
The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.
North America dominates the digital therapeutics market, with the U.S. accounting for the major share and highest CAGR. This can be attributed to the growing incidence of chronic diseases, government initiatives to support technological advancements in digital therapeutics, gradually improving reimbursement structure for digital therapeutics solutions, and a growing influx of new startup companies in the market as a result of increasing investments in the digital therapeutics field. For instance, in July 2014, Proteus Digital Health (U.S.) secured an investment of USD 172 million from a list of institutional investors for the manufacturing and development of its digital medicine products. Furthermore, in January 2014, WellDoc, Inc. (U.S.) received USD 20 million from the Merck Global Health Innovation Fund (U.S.), which it used to commercialize its products in the U.S. Such investments are likely to spur the growth of the market in North America in the coming years.